EGFR and neoplasm: Several RTKs, such as epidermal growth factor receptor (EGFR), PDGFR, and vascular endothelial growth factor receptor (VEGFR), are overexpressed and/or overactivated in HGG, further activating multiple signaling pathways involved in tumor growth, proliferation, and invasion [20, 21].